◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

SUPERNUS PHARMACEUTICALS, INC.

CIK: 1356576 SIC: 2834
$718.95M
Revenue
$-38.55M
Net Income
89.63%
Gross Margin
-8.66%
Op. Margin
$164.62M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 13 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $718.95M $718.95M $661.82M $607.52M $667.24M $579.77M
Revenue Growth % 0.0% 8.6% 8.9% -8.9% 15.1% nan%
Cost of Revenue $74.56M $74.56M $77.91M $83.78M $87.22M $75.06M
+ Gross Profit $644.39M $644.39M $583.91M $523.74M $580.02M $504.71M
Gross Margin % 89.6% 89.6% 88.2% 86.2% 86.9% 87.1%
Operating Expenses $781.24M $781.24M $580.15M $612.79M $621.11M $493.75M
Research & Development $106.23M $106.23M $108.80M $91.59M $74.55M $90.47M
Selling General & Admin $485.56M $485.56M $321.58M $336.36M $377.22M $304.76M
+ Operating Income $-62.28M $-62.28M $81.67M $-5.27M $46.12M $86.03M
Operating Margin % -8.7% -8.7% 12.3% -0.9% 6.9% 14.8%
Interest Expense - - - $1.32M $2.52M $2.52M
Other Income/Expense $13.25M $13.25M $16.20M $8.04M $14.62M $-12.85M
Income Before Tax $-49.03M $-49.03M $97.87M $2.77M $60.74M $73.17M
Income Tax Expense $-10.48M $-10.48M $24.00M $1.45M $32.00K $19.75M
+ Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M
Net Margin % -5.4% -5.4% 11.2% 0.2% 9.1% 9.2%
Basic EPS -0.68 -0.68 1.34 0.02 1.13 1.01
Diluted EPS -0.68 -0.68 1.32 0.02 1.04 0.98
Basic Shares Outstanding - 56.5M 55.1M 54.5M 53.7M 53.1M
Diluted Shares Outstanding - 56.5M 56.0M 55.5M 61.7M 54.4M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $128.45M $69.33M $75.05M $93.12M $203.43M
Short-term Investments - - $179.82M $368.21M $136.25M
Accounts Receivable $187.80M $142.08M $144.16M $165.50M $148.93M
Inventory $112.48M $54.29M $77.41M $91.54M $85.96M
Other Current Assets $65.33M $36.09M $16.68M $15.78M $27.02M
Total Current Assets $644.18M $686.07M $493.11M $734.15M $601.59M
Property Plant & Equipment $10.53M $11.54M $13.53M - -
Goodwill $124.88M $117.02M $117.02M $117.02M $117.52M
Intangible Assets $569.46M $521.91M $599.89M $702.46M $784.69M
Long-term Investments - - $16.62M $93.90M $119.17M
Other Non-current Assets $63.80M $31.53M $37.51M $39.81M $49.23M
Total Assets $1.45B $1.37B $1.28B $1.70B $1.69B
Accounts Payable $2.68M $4.59M - - -
Accrued Liabilities $107.80M $76.35M - - -
Other Current Liabilities $38.22M - $4.28M $16.86M $20.13M
Total Current Liabilities $338.17M $292.40M $290.20M $687.96M $315.38M
Deferred Tax Liabilities - $4.96M $24.96M $49.81M $85.36M
Other Non-current Liabilities $22.19M $7.60M $6.42M $8.69M $16.38M
Total Liabilities $390.93M $332.34M $356.16M $816.30M $873.30M
Common Stock $57.00K $56.00K $55.00K $54.00K $53.00K
Retained Earnings $517.88M $556.43M $482.56M $481.25M $379.92M
Total Stockholders Equity $1.06B $1.04B $921.52M $886.20M $815.85M
Total Liabilities & Equity $1.45B $1.37B $1.28B $1.70B $1.69B
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-38.55M $-38.55M $73.86M $1.32M $60.71M $53.42M
Depreciation & Amortization $153.69M $91.56M $80.41M $84.86M $85.54M $32.59M
Stock-based Compensation $56.69M $33.05M $27.75M $26.76M $17.57M $17.91M
Deferred Income Tax $-9.94M $5.21M $-20.14M $-25.71M $-26.32M $-4.99M
Change in Receivables $24.62M $22.30M $-2.08M $-18.77M $16.37M $-3.87M
Change in Inventory $-6.85M $7.50M $-15.81M $-6.11M $17.86M $14.58M
Operating Cash Flow $167.06M $47.33M $171.95M $111.08M $116.83M $127.13M
Capital Expenditure $2.45M $1.34M $725.00K $551.00K $412.00K -
Acquisitions - $293.09M - - - $950.00K
Sales of Investments $1.20B $774.48M $498.87M $370.90M $190.74M -
Investing Cash Flow $48.13M $4.11M $-189.87M $268.73M $-216.66M $-81.91M
Stock Issued $44.98M $37.62M $14.91M $6.61M $12.42M $7.09M
Financing Cash Flow $-32.73M $9.13M $12.19M $-397.88M $-10.48M $-130.42M
Net Change in Cash $182.46M $60.57M $-5.72M $-18.07M $-110.31M $-85.21M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $192.10M - $507.38M -
Cost of Revenue $18.96M - $51.55M -
Operating Expenses $252.33M - $565.73M -
Research & Development $29.37M - $78.41M -
Selling General & Admin $179.68M - $363.17M -
Operating Income $-60.23M - $-58.35M -
Other Income/Expense $2.28M - $11.23M -
Income Before Tax $-57.95M - $-47.12M -
Income Tax Expense $-12.84M - $-12.67M -
Net Income $-45.12M $19.92M $-34.45M -
Basic EPS -0.80 - -0.61 -
Diluted EPS -0.80 - -0.61 -
Basic Shares Outstanding $56.55M - $56.13M -
Diluted Shares Outstanding $56.55M - $56.13M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $151.37M $69.33M
Accounts Receivable $171.25M $142.08M
Other Current Assets $62.08M $36.09M
Total Current Assets $593.89M $686.07M
Property Plant & Equipment $10.63M $11.54M
Goodwill $119.08M $117.02M
Intangible Assets $623.48M $521.91M
Other Non-current Assets $62.43M $31.53M
Total Assets $1.42B $1.37B
Other Current Liabilities $26.32M -
Total Current Liabilities $330.63M $292.40M
Deferred Tax Liabilities - $4.96M
Other Non-current Liabilities $7.82M $7.60M
Total Liabilities $370.09M $332.34M
Common Stock $57.00K $56.00K
Retained Earnings $521.98M $556.43M
Total Stockholders Equity $1.05B $1.04B
Total Liabilities & Equity $1.42B $1.37B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-45.12M $19.92M $-34.45M -
Depreciation & Amortization - - $66.55M -
Stock-based Compensation - - $23.40M -
Deferred Income Tax - - $-13.80M -
Change in Receivables - - $5.88M -
Change in Inventory - - $3.32M -
Operating Cash Flow - - $27.47M -
Capital Expenditure - - $911.00K -
Acquisitions - - $293.09M -
Sales of Investments - - $735.16M -
Investing Cash Flow - - $55.42M -
Stock Issued - - $29.06M -
Financing Cash Flow - - $604.00K -
Net Change in Cash - - $83.49M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...